Relafen and Haemochromatosis - from FDA reports


Summary

There is no Haemochromatosis reported by people who take Relafen yet. This review analyzes which people have Haemochromatosis with Relafen. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Relafen and have Haemochromatosis, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 21, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Haemochromatosis when taking Relafen?

Expand the study to include all drugs with the same ingredients

Haemochromatosis and drugs with ingredients of nabumetone.

Expand the study to include reports from both FDA and eHealthMe

Haemochromatosis and Relafen from FDA and eHealthMe reports

Relafen

Relafen has active ingredients of nabumetone. It is often used in arthritis. (latest outcomes from Relafen 5,524 users)

Haemochromatosis

Haemochromatosis (body to absorb more iron than usual from food) has been reported by people with multiple sclerosis, high blood pressure, rheumatoid arthritis, pain, iron overload (latest reports from 1,771 Haemochromatosis patients).

Browse all side effects of Relafen

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Haemochromatosis

Haemochromatosis

Could your condition cause Haemochromatosis

Haemochromatosis

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Relafen and have Haemochromatosis.

User reviews to the study

More reviews >